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      INTRODUCTION 
The disease caused by the novel coronavirus 
SARS-CoV-2 (COVID- 19) was first described in 
China in December 2019 and is characterized by 
the appearance of symptoms such as fever, dry 
cough, dyspnoea, rhinorrhoea, anosmia, and 
ageusia. The horizon of respiratory involvement 
ranges from an upper airway catarrh, that can go 
unnoticed, even severe pneumonia or syndrome 
acute respiratory illness due to coronavirus.1 
Although less frequently, dermatological 
manifestations have been described in association 
with COVID-19. In a study conducted by Recalcati 
in a sample of 88 cases, it was found that 18 
patients had cutaneous manifestations, including 3 
with generalized urticaria, 14 cases of 
erythematous rash, and one with varicelliform 
rash.2 These skin symptoms are not specific to 
COVID-19 and have characteristics similar to 
those that occur in other respiratory infections 
with common viral causes.  
 
CASE REPORT 
We present the case of a 49-year-old man with no 
relevant medical history who presented to the 
emergency room with dry cough and dyspnea of 
moderate efforts for 7 days. By profession, the 
subject was a taxi driver but denied any recent 
contact with tourists or passengers due to 
lockdown. The subject also denied use of alcohol 
and tobacco and was not on any long-term 
medication. No chronic comorbidities were 
evident. On physical examination, the patient was 






He was able to pass air in and out of the lungs 
normally. Chest x-ray revealed peripheral and 
bilateral pulmonary opacities, predominantly in 
the lower lobes. The observed signs and symptoms 
were compatible with COVID-19. The polymerase 
chain reaction test for SARS-CoV-2 was done 
which came out to be positive. He was admitted 
and treatment with hydroxychloroquine and 
lopinavir /ritonavir was initiated. The subject 
showed clinical improvement and polymerase 
chain reaction for coronavirus SARS-CoV-2 gave 
negative result after two weeks. The subject was 
discharged but second day after discharge, he 
presented again with slightly itchy erythematous 
maculopapular rash with islets of healthy skin on 
the trunk, which appeared suddenly. Topical 
betamethasone ointment was prescribed along 
with oral levocetirizine, but after few hours, the 
lesions extended to cervical region, face and 
proximal region of upper limbs, oral prednisone 
was added to his treatment regimen. The clinical 
response was favorable, with disappearance of 
lesions in a few days. 
 
DISCUSSION 
Cutaneous symptoms are not too common in 
COVID-19 cases and in most patients appear after 
hospital discharge, as in our case, and are not 
associated with increased severity of COVID-19. In 
a previously conducted study, the skin lesions in 
COVID-19 patients mainly affected the trunk, were 
asymptomatic or slightly pruritic and then 














Much is now known about the respiratory presentation of coronavirus SARS-CoV-2 (COVID-19) but it can also show up with 
clinical manifestations in other locations, such as on the skin. Herein, we describe a case with cutaneous symptoms that emerged 
during the recovery phase in a SARS-CoV-2 coronavirus infected patient. It is important for the healthcare professionals as well as 
the patients to know about such scenarios, so that appropriate action can be readily taken. 
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published case of COVID-19 was initially mistaken 
for dengue due to the similarity in cutaneous 
manifestations.3 Other dermatological 
manifestations to consider are those due to side 
effects of certain drugs used in the treatment of 
COVID-19. In particular, one must be aware of the 
possible adverse effects of hydroxychloroquine on 
the skin such as skin hyperpigmentation, pruritus, 
xerosis, alopecia, urticaria, morbilliform rashes or 
maculopapular and exfoliative dermatitis.4 
Azithromycin can also cause skin rashes, itching 
or Stevens-Johnson syndrome. The most common 
adverse effects of the drug lopinavir/ritonavir are 
maculopapular rashes, pruritus, eczema and 
seborrheic dermatitis. Micro-thrombosis related to 
endothelial damage and vascular disorders in 
COVID-19 may also lead to other more serious 
skin lesions. They are ischemic lesions of sudden 
onset, characterized by cyanosis, blistering and 
dry gangrene of the fingers and toes.5 
 
CONCLUSION 
It is evident from the literature that COVID-19 can 
lead to skin manifestations, more studies are 
needed to know all the forms of presentation and 
confirm the causal relationship with coronavirus 
infection. It is important to rule out all other 
causes of skin lesions in COVID-19 affected 
subjects. For timely appropriate action, regular 
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